<DOC>
	<DOC>NCT01707550</DOC>
	<brief_summary>This observational survey study will capture all renal transplant patients in Serbia who are currently receiving CellCept (mycophenolate mofetil) as part of their immunosuppressive protocol.</brief_summary>
	<brief_title>An Observational Study of CellCept (Mycophenolate Mofetil) in Renal Allograft Recipients</brief_title>
	<detailed_description />
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>Adult patients, &gt;/= 18 years of age Recipients of renal allograft Patients receiving CellCept</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>